Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Investigation for XYZAL

NCT01445262 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01445262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01445262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Investigation for XYZAL
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2013
Enrollment
10,728 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, allergic, perennial and seasonal